Aberrant responses in social interaction of dopamine transporter knockout mice

Behavioural Brain Research

Volumn 148, Issue 1-2, 2004, Pages 185-198

  Rodriguiz, Ramona M ^a   Chu, Richard ^a   Caron, Marc G ^a   Wetsel, William C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dopamine; Dopamine transporter; Mice; Psychiatric disorder; Social interaction

Indexed keywords

DOPAMINE TRANSPORTER;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENVIRONMENTAL EXPOSURE; EXPERIMENTAL MODEL; FEMALE; KNOCKOUT MOUSE; MALE; MENTAL DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOCIAL BEHAVIOR; SOCIAL INTERACTION;

EID: 0347626244     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(03)00187-6     Document Type: Article

References (54)

1. American Psychological Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychological Association; 1994.
2. Astrachan B.M., Harrow M., Adler D., Brauer L., Schwartz A., Schwartz C.et al. A checklist for the diagnosis of schizophrenia. Br. J. Psychiatry. 121:1972;529-539.
3. Bakeman R, Gottman JM. Observing interaction: an introduction to sequential analyses. New York: Cambridge University Press; 1997.
4. Baum M.J., Keverne E.B. Sex difference in attraction thresholds for volatile odors from male and estrus female mouse urine. Horm. Behav. 41:2000;213-219.
5. Benus R.F., Bohus B., Koolhaas J.M., van Oortmerssen G.A. Behavioural differences between artificially selected aggressive and nonaggressive mice: response to apomorphine. Behav. Brain Res. 43:1991;203-208.
6. Bleuler E. Dementia praecox or the group of schizophrenias. New York: International University Press; 1950.
7. Brain P.F. What does individual housing mean to a mouse? Life Sci. 16:1975;187-200.
8. Cabib S., Puglisi-Allegra S. Opposite responses of mesolimbic dopamine system to controllable and uncontrollable aversive experiences. J. Neurosci. 14:1994;3333-3340.
9. Cairns RB. Fighting and punishment from a developmental perspective. In: Cole JK, Jensen DD, editors. Nebraska Symposium on Motivation. Nebraska: University of Nebraska Press; 1972. p. 59-124.
10. Cairns R.B., Hood K.E., Midlam J. On fighting in mice: is there a sensitive period for isolation effects? Anim. Behav. 33:1985;166-180.
11. Cairns R.B., MacCombie D.J., Hood K.E. A developmental-genetic analyses of fighting in mice: I. Behavioral outcomes. J. Comp. Physiol. Psychol. 97:1983;69-89.
12. Cairns R.B., Scholz S.D. Fighting in mice: dyadic escalation and what is learned. J. Comp. Physiol. Psychol. 85:1973;540-550.
13. Citrome L., Volavka J., Czobor P., Sheitman B., Lindenmayer J.-P., McEvoy J.et al. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. Psychiatr. Serv. 52:2001;1510-1514.
14. Creese I., Iversen S.D. The role of forebrain dopamine system in amphetamine-induced stereotyped behavior in the rat. Psychopharmacology (Berl.). 39:1974;357-394.
15. Crowcroft P., Rowe F.P. Social organization and territorial behavior of wild house mice. Proc. Zool. Soc. Lond. 140:1958;517-531.
16. Del Punta K., Leinders-Zufall T., Rodriguez I., Jukam D., Wysocki C., Sonoko O.et al. Deficient pheromone responses in mice lacking a cluster of vemeronasal receptor genes. Nature. 419:2002;70-74.
17. Ellinwood EH, Sudilovsky A. Chronic amphetamine intoxication: behavioral model of psychoses. In: Cole JO, Freedman AM, Friedhoff AJ, editors. Psychopathology and psychopharmacology. Maryland: Johns Hopkins University Press; 1973. p. 51-70.
18. Ellinwood E.H., Sudilovsky A., Nelson L.M. Behavioral analyses of chronic amphetamine intoxication. Biol. Psychiatry. 4:1972;215-225.
19. Filibeck U., Cabib S., Castellano C., Puglisi-Allegra S. Chronic cocaine enhances defensive behaviour in the laboratory mouse: involvement of D2 dopamine receptors. Psychopharmacologia. 96:1988;437-441.
20. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science. 283:1999;397-401.
21. Gambill J.D., Kornetsky C. Effects of chronic D-amphetamine on social behavior of the rat: implications for an animal model of paranoid schizophrenia. Psychopharmacology (Berl.). 50:1976;215-223.
22. Gariepy J.L., Rodriguiz R.M. Issues of establishment, consolidation, and reorganization of biobehavioral adaptation. Brain Mind. 3:2002;53-77.
23. Gendreau P.L., Petitto J.M., Gariepy J.L., Lewis M.H. D1 dopamine receptor mediation of social and nonsocial emotional reactivity in mice: effects of housing and strain difference in motor activity. Behav. Neurosci. 111:1997;424-434.
24. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;601-612.
25. Haber S, Barchas PR, Barchas JD. Effects of amphetamine on social behaviors of rhesus macaques: an animal model of paranoia. In: Hanin I, Usdin E, editors. Animal models in psychiatry and neurology. New York: Pergamon Press; 1977. p. 107-14.
26. Hatfield T., Graham P.W., Gallagher M. Taste-potentiated odor aversion learning: role of the amygdaloid basolateral complex and central nucleus. Behav. Neurosci. 106:1992;286-293.
27. Hood K.E., Cairns R.B. A developmental-genetic analyses of aggressive behavior in mice: IV. Genotype-environment interactions. Aggres. Behav. 15:1989;361-380.
28. Hoza B., Pelham W.E., Dobbs J., Owens J.S., Pillow D.R. Do boys with attention-deficit hyperactivity disorder have positive self-illusory self-concepts? J. Abnorm. Psychol. 111:2002;268-278.
29. Jones S.R., Gainetdinov R.R., Jaber M., Giros B., Wightman R.M., Caron M.G. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl. Acad. Sci. U.S.A. 95:1998;4029-4034.
30. Jones S.R., Gainetdinov R.R., Wightman R.M., Caron M.G. Mechanisms of amphetamine action revealed in mice lacking dopamine transporter. J. Neurosci. 18:1998;1979-1986.
31. Jones S.R., Gainetdinov R.R., Xiu T.H., Cooper D.C., Wightman R.M., White F.J.et al. Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat. Neurosci. 2:1999;649-655.
32. Jones R.B., Nowell N.W. Aversive potency of urine from dominant and subordinate male laboratory mice (Mus musculus): resolution of a conflict. Aggres. Behav. 15:1989;291-296.
33. Lagerspetz K.M.J., Lagerspetz K.Y.H. Changes in aggressiveness of mice resulting from selective breeding, learning, and social isolation. Scand. J. Psychol. 12:1971;241-248.
34. Lee CT, Ingersoll DW. Pheromonal influences on aggressive behavior. In: Svare B, editor. Hormones and aggressive behavior. New York: Plenum Press; 1983. p. 373-404.
35. LeMoal M., Simon H. Mesocorticolimibic dopaminergic network: functional and regulatory roles. Physiol. Rev. 71:1991;155-234.
36. Liebenauer L.L., Slotnick B.M. Social organization and aggression in a group of olfactory bulbectomized male mice. Physiol. Behav. 60:1996;403-409.
37. Lijam J., Paylor R., McDonald M., Crawley J.N., Deng C.X., Herrup K.et al. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell. 90:1997;895-905.
38. Lyon M. Animal models of mania and schizophrenia. In: Wilner P, editor. Behavioural models in psychopharmacology: theoretical, industrial, and clinical perspectives. New York: Cambridge University Press; 1991. p. 253-310.
39. Mackintosh J.H. Territory formation by laboratory mice. Anim. Behav. 18:1970;177-183.
40. Miczek K.A., Gold L.H. D-Amphetamine in squirrel monkeys of different social status: effects on social and agonistic behavior, locomotion and stereotypies. Psychopharmacology (Berl.). 81:1983;183-190.
41. Miczek K.A., Weerts E., Haney M., Tidey J. Neurobiological mechanisms controlling aggression: preclinical developments for pharmaceutical interventions. Neurosci. Biobehav. Rev. 18:1994;97-110.
42. Moro M., Salvador A., Simon V.M. Changes in the structure of agonistic behavior of mice produced by D-amphetamine. Pharmacol. Biochem. Behav. 56:1997;46-54.
43. Ralph R.J., Paulus M.P., Fumagalli F., Caron M.G., Geyer M.G. Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knockout mice: differential effects of D1 and D2 receptor antagonists. J. Neurosci. 21:2001;305-313.
44. Rampon C., Tang Y.P., Goodhouse J., Shimizu E., Kyin M., Tsien J.Z. Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice. Nature. 3:2000;238-244.
45. Ryan J.M. Pharmacologic approach to aggression in neuropsychiatric disorders. Semin. Clin. Neuropsychiatry. 5:2000;238-249.
46. Seiden L.S., Sabol K.E., Ricaurte G.A. Amphetamine: effects on catecholamine systems and behavior. Ann. Rev. Pharmacol. Toxicol. 32:1993;639-677.
47. Sluyter F., Bohous B., Beldhuis H.J.A., van Oortmerssen G.A. Autosomal and Y chromosome effects on stereotyped response to apomorphine in wild house mice. Pharm. Biochem. Behav. 52:1995;17-22.
48. Smith D.R., Striplin C.D., Geller A.M., Mailman R.B., Drago J., Lawler C.P.et al. Behavioural assessment of mice lacking D1A dopamine receptors. Neuroscience. 86:1998;135-146.
49. Spielewoy C., Roubert C., Hamon M., Nosten-Bertrand M., Betancur C., Giros B. Behavioural disturbances associated with hyperdopaminergia in dopamine transporter knockout mice. Behav. Pharmacol. 11:2000;279-290.
50. Steinert T., Weibe C., Gebhardt R.P. Aggressive behavior against self and others among first-adminssion patients with schizophrenia. Psychiatr. Serv. 50:1999;85-90.
51. Tidey J.W., Miczek K.A. Social defeat stress selectively alters mesocorticolimibic dopamine release: an in vivo microdialysis study. Brain Res. 721:1996;140-149.
52. Urich J. The social hierarchy in albino mice. J. Comp. Psychol. 25:1938;373-413.
53. Van Loo P.L.P., Kruitwagen C.L.J.J., Van Zutphen L.F.M., Koolhaas J.M., Baumans V. Modulation of aggression in male mice: influence of cage cleaning regimen and scent marks. Anim. Welfare. 9:2000;281-295.
54. Wright S., Klee H. Violent crime, aggression and amphetamine: what are the implications for drug treatment services. Drugs Educ. Prev. Policy. 8:2001;73-90.